Pricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Raw

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Research and development91735-----1391292
General and administrative10142012-754679117
Long-lived assets impairment-----------2-
Right of use asset impairment-----------0-
Loss on sale of fixed assets--------123,176--73,000---56,000
Total operating expenses19315539341716111916212210
Interest income--------77,00012,0004,0000348,000
Rental income------------305,000
Gain from elimination of ARO obligation, net------------289,000
Derivative gain-1,555,497205,768-516,840--78,038-915,141-36,218,832455-046-
Total other income-7,142,593227,711-504,55322,263-411,798-2,081,275-36,326,989-5-60,00036942,000
Net loss-18,359,234-11,593,045-24,008,558-38,125,415-32,010,242-19,163,629-51,891,94534-13,630,000-15,894,000-17,075,000-16,337,000-8,632,000
Earnings Per Share, Basic---------0.1-0.09-0.09-1.08-10.66
Earnings Per Share, Diluted---------0.14-0.09-0.1-1.47-10.66